Compared to Estimates, OPKO Health (OPK) Q3 Earnings: A Look at Key Metrics

Core Insights - OPKO Health reported revenue of $151.7 million for the quarter ended September 2025, a decrease of 12.6% year-over-year, and EPS remained unchanged at $0.03 compared to the same quarter last year [1] - The revenue fell short of the Zacks Consensus Estimate of $157.11 million, resulting in a surprise of -3.44%, while the EPS exceeded expectations with a surprise of +250% against a consensus estimate of -$0.02 [1] Revenue Breakdown - Revenue from services was $95.2 million, below the average estimate of $96.86 million, reflecting a year-over-year decline of 21.5% [4] - Revenue from the transfer of intellectual property and other sources reached $18.8 million, slightly above the estimated $18.46 million, marking a significant increase of 42.4% year-over-year [4] - Revenue from products totaled $37.7 million, which was lower than the average estimate of $41.79 million, indicating a year-over-year decrease of 3.6% [4] Stock Performance - Over the past month, OPKO Health's shares have returned -7.1%, contrasting with the Zacks S&P 500 composite's increase of +3.8% [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential for outperformance in the near term [3]